2017_11_09_Published.jpg
Flutes.png
photo-1425036458755-dc303a604201.jpeg
Denali_1.jpg
2017_11_09_Published.jpg

PEOPLE


We are a team dedicated to defeating degeneration. We are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop therapies that will change the lives of patients suffering from neurodegenerative disease.

SCROLL DOWN

PEOPLE


We are a team dedicated to defeating degeneration. We are passionate about solving problems with rigorous science and translational medicine. We have joined together to discover and develop therapies that will change the lives of patients suffering from neurodegenerative disease.

Flutes.png

FOUNDERS


Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and founding investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines.

FOUNDERS


Denali was founded by Drs. Marc Tessier-Lavigne, Ryan Watts, Alex Schuth and founding investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines.

photo-1425036458755-dc303a604201.jpeg

BOARD OF DIRECTORS


Success is accelerated by experience, collaboration and leadership. Denali’s Board of Directors combines expertise across industry, academia, drug development and the investment community, unified by the mission to improve the lives of patients.

BOARD OF DIRECTORS


Success is accelerated by experience, collaboration and leadership. Denali’s Board of Directors combines expertise across industry, academia, drug development and the investment community, unified by the mission to improve the lives of patients.

DOUGLAS COLE

Managing Partner of Flagship PIONEERING

JAY FLATLEY

CHAIRMAN of Illumina, Inc.

ROBERT NELSEN

Managing DIRECTOR & CO-FOUNDER of ARCH Venture Partners

VICKI SATO, CHAIR

CHAIRMAN OF DENALI THERAPEUTICS, INC.

DAVID SCHENKEIN

CEO of Agios Pharmaceuticals, Inc.

MARC TESSIER-LAVIGNE

PRESIDENt OF STANFORD UNIVERSITY

RYAN WATTS

Denali Therapeutics Inc.

Denali_1.jpg

SCIENTIFIC ADVISORY BOARD


Denali is collaborating with some of the brightest minds in academia and industry to defeat degeneration.

SCIENTIFIC ADVISORY BOARD


Denali is collaborating with some of the brightest minds in academia and industry to defeat degeneration.

SCOTT BILLER

AGIOS PHARMACEUTICALS

ALISON GOATE

MOUNT SINAI

DAVID HOLTZMAN

WASHINGTON UNIVERSITY

LEONARD PETRUCELLI

MAYO CLINIC

ERIC REIMAN

BANNER ALZHEIMER'S INSTITUTE

LEE RUBIN

HARVARD UNIVERSITY

KEVAN SHOKAT

UNIVERSITY OF CALIFORNIA SAN FRANCISCO

SCOTT SMALL

COLUMBIA UNIVERSITY

MARC TESSIER-LAVIGNE

Stanford UNIVERSITY

HUDA ZOGHBI

BAYLOR UNIVERSITY